retatrutide mechanism triple agonist gip glp-1 glucagon retatrutide ly3437943 is not “just another GLP1.” It Retatrutide vs Tirzepatide & Semaglutide

Weight regain and cardiometabolic effects after withdrawal of semaglutide (STEP 1 extension)

This compound is supplied strictly for laboratory research use only

In contrast, nearly 60% of patients in CREDENCE had an eGFR less than 60 ml/min (88)

Key considerations for sequential study design: Semaglutide half-life: Approximately 7 days full clearance takes approximately 5 half-lives (35 days) Retatrutide half-life: Approximately 6 days similar clearance timeline Adequate clearance periods prevent pharmacological overlap between study phases Sequential protocols allow comparative analysis without the confounding variables of combination use Sequential study designs are established methodology

GLP-1 :20231124 :20231207 GLP-1GLP-1 GLP-1GLP-1GLP-1 GLP-1GLP-1 GLP-1 GLP-13 GLP-1 GLP-1 GLP-13 1

Xu, E., Xie, Y